Furthermore, the decreased percentage of CD4+FoxP3+ T cells in the total lung lymphocyte population of IFT88 KO mice is not dependent on infection with Mabs and is apparent 3 months after deletion of the IFT88 gene (treatment with tamoxifen). The gene discussed is FOXP3; the disease is infection.